Oxford Vaccine By Serum Institute May Get Govt Nod in India
Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...
Get authentic, real-time news that helps you fight COVID-19 better.
Install PlexusMD App for doctors. It's free.
Amid fears of a new variant, Pune’s Serum Institute of India (SII) may be able to get approval for the Oxford-AstraZeneca vaccine against coronavirus before the UK where it was originally developed. The Drug Controller of India is expected to clear the Oxford vaccine shot for emergency use in the coming weeks.

The government committee for vaccine approval is currently going through applications of Pfizer, Serum Institute’s Oxford vaccine and Bharat Biotech that have sought for emergency use in India. The committee said it will release one of these vaccines to the public as soon as the clinical data provided is found satisfactory.

An official familiar with the development told that discussions between the government and Serum Institute are underway for procurement of Covishield doses and a decision on it could be formally announced as early as this week.

The Centre said the applications by Bharat Biotech, Serum Institute of India and Pfizer filed with the Drugs Controller General of India are being examined by the COVID-19 subject expert committee of Central Drugs Standard Control Organization (CDSCO).

The parliamentary committee report noted that the CDSCO has given no emergency use authorisation in the past, and suggested that all necessary and mandatory requirements must be duly fulfilled and all trial phases completed.